Rovio Entertainment Corp.
Rovio Entertainment Corporation Stock Exchange Release January 8, 2021 at 10 a.m. EET
Changes in the holding of company’s own shares
Rovio Entertainment Corporation has on January 7, 2021 transferred without consideration a total of 29 527 Company's own shares to Company's management team member based on the Company's share-based incentive scheme.
Following the transfer, Company holds total of 7 819 808 its own shares.
ROVIO ENTERTAINMENT CORPORATION
More information:
Rene Lindell, CFO
RovioIR@rovio.com
Media desk: +358 40 4858985
Distribution:
Nasdaq Helsinki Ltd
Key media
https://investors.rovio.com/en
About Rovio:
Rovio Entertainment Corporation is a global, mobile-first games company that creates, develops and publishes mobile games, which have been downloaded over 4.5 billion times so far. Rovio is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainment and consumer products in brand licensing. Today, Rovio offers multiple mobile games, animations and produced The Angry Birds Movie in 2016. Its sequel, The Angry Birds Movie 2, was released in 2019. Rovio is headquartered in Finland and the company's shares are listed on the main list of NASDAQ Helsinki stock exchange with the trading code ROVIO. (www.rovio.com)
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
VoltaGrid LLC20.10.2025 23:15:00 CEST | Press release
VoltaGrid and Halliburton Announce Strategic Collaboration to Deliver Distributed Power Solutions for the Global Data Center Industry
Teva Pharmaceutical Industries Ltd20.10.2025 22:30:00 CEST | Press release
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
Vicor Corporation20.10.2025 21:50:00 CEST | Press release
Vicor steps up its IP licensing practice
Biotalys NV20.10.2025 18:00:00 CEST | Press release
Regulated information
Syensqo SA20.10.2025 17:45:00 CEST | Press release
Syensqo - Acquisition of own shares
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom